When Healthcare Goes Direct to the Customer, What Happens to Care?
Private equity is taking another look at healthcare.
In The Weekend Pitch, PitchBook's Esther Luz describes investors moving beyond traditional physician-practice roll-ups toward services patients pay for directly: weight management, hormone therapy, medical aesthetics, and concierge care.
The economic attraction is understandable. These businesses can reduce dependence on insurance reimbursement while creating opportunities for differentiated services and growth.
But a changing revenue model raises an operating question: What happens to the provider-patient relationship when growth, technology, and clinical care must scale together?
AI may help manage scheduling, patient communications, administrative work, and aspects of clinical decision support. Some applications could improve access and quality while reducing costs.
Others may introduce new risks or alter relationships that patients value.
The distinction matters.
The question isn't whether healthcare organizations should use AI. It's which decisions can be delegated, which require clinical judgment, and what evidence should determine the difference.
As private capital expands into consumer-facing healthcare, operating performance cannot be measured solely by revenue growth, margins, or patient volume.
Quality, accountability, and the patient relationship remain part of the value being created—or potentially lost.
The investment thesis may change. The responsibility for care does not.
Source: Esther Luz, “PE goes out of network in healthcare, for some cash injection,” PitchBook, October 25, 2026.
Related reading: Our earlier examination of OpenEvidence and the evolving relationship between AI, physicians, and patients. OpenEvidence: When the Answer Matters.
